Ebola virus outbreaks in sub-Saharan Africa
Citation: Rugarabamu S, Mboera L, Rweyemamu M, et al. Forty-two years of responding to Ebola virus outbreaks in Sub-Saharan Africa: a review. BMJ Global Health. 2020 Mar 1;5(3):e001955.
What is this? The COVID-19 pandemic is having a substantial impact on society. Existing research on the impact of other infectious disease outbreaks, such as Ebola viral disease (EVD) in Sub-Saharan Africa, might provide useful information for policy makers.
In this systematic review, the authors searched for studies on EVD outbreaks in Sub-Saharan Africa identifying challenges and opportunities in its detection and response. They restricted their searches to articles published in English from July 1976 to July 2019. They included 100 studies, including 30 epidemiological studies, 20 articles on prevention and control, 27 outbreak reports and 23 articles discussing challenges, opportunities, or other topics.
What was found: EVD outbreaks are related to epidemiological, sociocultural and health system factors.
Control measures including case management, vaccination, active surveillance, and case identification and isolation have helped to contain EVD outbreaks.
Establishing trust and confidence in response efforts through education and engagement of community members were important for reducing the spread of EVD.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.